- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.09. | Exact Sciences scares up spooky season Cologuard campaign starring Matthew Lillard | ||
| 22.09. | With new FDA nod in ulcerative colitis, J&J's Tremfya becomes 1st IL-23 med with IV and subQ options across IBD treatment | ||
| 19.09. | Merck scores FDA approval for subcutaneous Keytruda, securing potential blockbuster protection | ||
| 19.09. | Takeda scientists tackle Mount Fuji to advocate for patients in need of plasma-derived therapies | ||
| 19.09. | CDC 'strongly' backs Gilead's HIV PrEP Yeztugo, but advocacy groups say access barriers remain | ||
| 19.09. | Novo's once-weekly combo drug for type 2 diabetes scores EU endorsement | ||
| 19.09. | 'Bombardment of spam' lands Eli Lilly in hot water with UK marketing watchdog | ||
| 19.09. | Rebuilding trust in pharma in the age of misinformation | ||
| 19.09. | Moderna, Alnylam resolve patent litigation over COVID-19 vaccine delivery tech | ||
| 18.09. | Fujifilm, argenx expand partnership to bring Vyvgart production to the US | ||
| 18.09. | Genentech names next marketing chief as Erica Taylor takes on new role at Roche | ||
| 18.09. | After trial win, Lilly's Mounjaro primed for expansion in kids 10-17 with type 2 diabetes | ||
| 18.09. | After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics | ||
| 18.09. | Novo Nordisk pads case for Wegovy in a pill as oral obesity asset nears FDA decision | ||
| 18.09. | Insulet enlists Pantone for color-focused push to make Omnipod pump the pick of the bunch | ||
| 18.09. | MilliporeSigma debuts €150M filtration plant as part of larger investment in Ireland | ||
| 17.09. | RFK Jr. demanded vaccine policy change without evidence, fired CDC director testifies | ||
| 17.09. | Cost-cutting X4 chops head count by 50%, lays off execs in mission to complete Xolremdi expansion study | ||
| 17.09. | In New Jersey, Novo Nordisk cuts 263 workers while BMS slashes 282 roles | ||
| 17.09. | ChatGPT: Friend or foe to pharma marketers? Inizio Evoke chief innovation officer weighs in | ||
| 17.09. | AstraZeneca's Fasenra comes up short again in COPD as injectable Saphnelo makes grade in lupus | ||
| 17.09. | SK's blockbuster hopeful Xcopri reduces seizures in phase 3 trial, teeing up FDA expansion bid | ||
| 16.09. | AGC Biologics telegraphs 278 layoffs as it plots sale of Colo. manufacturing plants | ||
| 16.09. | FDA targets Lilly, Novartis, BMS and more in deluge of marketing letters | ||
| 16.09. | AstraZeneca TV spot for at-home FluMist lands in FDA crosshairs as DTC ad crackdown ramps up |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .